Roche Holdings AGRHHBY recently launched CE-IVD - the cobas MRSA/SA nucleic acid test. The test will be used on the cobas Liat System for the qualitative detection and differentiation of ...
PLEASANTON, Calif., June 4, 2015 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has provided 510(k) clearance for the cobas® HSV 1 ...
The FDA approvals of Roche Holdings' RHHBY Hemlibra or Cobas Cdiff Nucleic acid test and Thermo Fisher Scientific's TMO slew of advancements in next-generation sequencing (the latest one being the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results